tiprankstipranks
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market
CABA
Cabaletta Bio
RESEARCH TOOLSreports
Want to see CABA full AI Analyst Report?

Cabaletta Bio (CABA) Stock News & Sentiment

1,545 Followers
Cabaletta Bio Maintained at Buy as Emerging Rese-cel Data Support Preconditioning-Free Potential; $13 Price Target Reaffirmed
Premium
Ratings
Cabaletta Bio Maintained at Buy as Emerging Rese-cel Data Support Preconditioning-Free Potential; $13 Price Target Reaffirmed
2d ago
CABA
Cabaletta Bio Announces $150 Million Equity Offering
Premium
Company Announcements
Cabaletta Bio Announces $150 Million Equity Offering
3d ago
8K
CABA
Cabaletta Bio reports promising RESET-PV and RESET-SLE data
Premium
Company Announcements
Cabaletta Bio reports promising RESET-PV and RESET-SLE data
3d ago
8K
CABA
Cabaletta Bio: Buy Rating Reiterated as Rese-cel Data and Cellares Partnership Support Unchanged $16 Price Target
Premium
Ratings
Cabaletta Bio: Buy Rating Reiterated as Rese-cel Data and Cellares Partnership Support Unchanged $16 Price Target
8d ago
CABA
Cabaletta Bio: RESET-MG Data and Differentiated Autoimmune Strategy Underpin Buy Rating and Upside Potential
Premium
Ratings
Cabaletta Bio: RESET-MG Data and Differentiated Autoimmune Strategy Underpin Buy Rating and Upside Potential
16d ago
CABA
Cabaletta Bio Updates rese-cel Autoimmune Therapy Development Plans
Premium
Company Announcements
Cabaletta Bio Updates rese-cel Autoimmune Therapy Development Plans
17d ago
8K
CABA
Morgan Stanley and Jefferies Analysts Forecast Over 350% Upside Potential for Cabaletta Bio Stock
Premium
Market News
Morgan Stanley and Jefferies Analysts Forecast Over 350% Upside Potential for Cabaletta Bio Stock
1M ago
MS
JEF
More CABA News >

CABA News on the Web

Patients dosed with Cabaletta’s rese-cel manufactured on Cellares’ Cell Shuttle
TipRanks News
Bullish
H.C. Wainwright Remains a Buy on Cabaletta Bio (CABA)
TipRanks News
Bullish
This Biotech Stock Could Deliver 350% Returns in 12 Months
GuruFocus News
Bullish
Wells Fargo Issues a Hold Rating on Cabaletta Bio (CABA)
TipRanks News
Neutral
Morgan Stanley and Jefferies Analysts Forecast Over 350% Upside Potential for Cabaletta Bio Stock
TipRanks News
Bullish
Cabaletta Bio price target lowered to $13 from $14 at Morgan Stanley
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Cabaletta Bio (CABA), Insmed (INSM)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Cabaletta Bio (CABA)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CABA
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CABA’s Media Buzz Sentiment?
1 articles about CABA were published this week. In an average week, 3.5 articles are published.
    What is CABA’s weekly average amount of articles?
    In an average week, 3.5 articles about CABA are published.
      What is CABA’s News Sentiment?
      100% of articles about CABA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week